Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Entire DC Network
Clinical Evaluation Of Basal-Bolus Therapy Delivered By The V-Go® Wearable Insulin Delivery Device In Patients With Type 2 Diabetes: A Retrospective Analysis, Trisha Zeidan, Carla Nikkel, Beth Dziengelewski, Stephanie Wu, Aleda Chen
Clinical Evaluation Of Basal-Bolus Therapy Delivered By The V-Go® Wearable Insulin Delivery Device In Patients With Type 2 Diabetes: A Retrospective Analysis, Trisha Zeidan, Carla Nikkel, Beth Dziengelewski, Stephanie Wu, Aleda Chen
Pharmacy Practice Faculty Publications
Insulin therapy is frequently required to achieve glycemic targets (A1c) in type 2 diabetes (T2D); however, clinicians and patients face barriers with the complexities of multiple daily injection regimens. Patch-like wearable insulin devices, such as V-Go, may simplify and optimize this complexity. This study evaluated the change in A1C and insulin total daily dose (TDD) in a suboptimally-controlled (not achieving A1C targets) T2D population after switching to V-Go. A retrospective chart analysis at a diabetes clinic was performed to evaluate change in A1c measurements from baseline (V-Go initiation) to end of study observation. Of the 139 patients enrolled, A1C significantly …